Drug Screening Market on Track for Strong Growth, Estimated to Grow at 15% CAGR Through 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Drug Screening Market Through 2025?
The size of the drug screening market has seen a rapid expansion in recent years. Its growth is expected to escalate from $8.57 billion in 2024 to $9.79 billion in 2025, projecting a compound annual growth rate (CAGR) of 14.2%. Factors contributing to the surge in the historic period include pharmaceutical drug analysis, healthcare and clinical assessment, substance misuse therapy, R&D expenditure, along with the rising adoption of drug testing kits and gadgets.

What's the Projected Size of the Global Drug Screening Market by 2029?
The market size of drug screening is predicted to experience a significant increase in the following years, reaching $17.1 billion in 2029, with a compound annual growth rate (CAGR) of 15.0%. This growth for the forecasted period can be linked to factors such as the legalization of cannabis* and the opioid crisis, a surge in sports events, quick and point-of-care testing, changing drug policies and regulations, an increase in health and wellness programs in workplaces, as well as the expansion of the international market. Key trends to watch for in the forecast period include heightened drug detection technologies, the rise of telemedicine and remote testing, investment inflow into research and development, cutting-edge drug testing kits and devices, and technological enhancements in testing procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Top Growth Drivers in the Drug Screening Industry: What's Accelerating the Market?
The escalating usage of drugs and alcohol is anticipated to drive the growth of the drug screening market. Drug addiction, which affects an individual's brain and behavior leading to an uncontrollable urge to use either legal or illegal drugs or medication, is a disease. Substances like alcohol, marijuana, and nicotine are also categorized as drugs. The increase in drug and alcohol addiction subsequently elevates the risk of diseases, fueling the demand for drug screening. For instance, in 2022, the global concern over drug and alcohol consumption remained significant. The National Survey on Drug Use and Health (NSDUH) disclosed that 13.5% of Americans aged 12 and older used drugs in the past month, reflecting a 3.8% yearly increase. The study further revealed that 59.277 million or 21.4% of individuals aged 12 and older misused prescription drugs or used illegal drugs within the past year. The effects of the pandemic have also increased drug risks, with youth's cannabis* usage rising up to fourfold in certain areas globally. Therefore, the rise in drug and alcohol consumption is paving the way for the growth of the drug screening market during the forecasted period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

What Trends Will Shape the Drug Screening Market Through 2029 and Beyond?
The emergence of ground-breaking products is a significant trend gaining traction in the drug screening market. Major players in this market are concentrating on creating and introducing new products to satisfy the rapidly expanding industry requirements and solidify their market standing. Moreover, the sudden shift in drug screening strategies due to COVID has altered the screening procedures, fostering innovation and the development of new products from companies. These companies are striving to create innovative products like a highly effective new drug test that can be extensively utilized by laboratories. A case in point, in September 2022, Sysmex Corporation, a healthcare firm based in Japan, introduced a novel product for urine sediment testing and screening called the UF-1500 Fully Automated Urine Particle Testing Analyzer. This new product retains the excellent functionality and user-friendliness of the UF-5000 Fully Automated Urine Particle Analyzer, Sysmex's top-of-the-line model for urine sediment testing, while reducing the size of the former model.

What Are the Main Segments in the Drug Screening Market?
The drug screening market covered in this report is segmented -

1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:
1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards
3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Which Top Companies are Driving Growth in the Drug Screening Market?
Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Which Regions Will Dominate the Drug Screening Market Through 2029?
North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6369

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.